Cargando…

A novel herbal treatment reduces depressive-like behaviors and increases brain-derived neurotrophic factor levels in the brain of type 2 diabetic rats

BACKGROUND: Radix Puerariae and hawthorn fruit have been demonstrated to treat diabetes. They offer potential benefits for preventing depression in diabetes. OBJECTIVE: The aim of this study was to investigate whether the combination of Radix Puerariae and hawthorn fruit (CRPHF) could prevent depres...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Chun, Ke, Yuting, Yuan, Yanyan, Zhao, Ming, Wang, Fuyan, Zhang, Yisheng, Bu, Shizhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5136358/
https://www.ncbi.nlm.nih.gov/pubmed/27942216
http://dx.doi.org/10.2147/NDT.S117337
_version_ 1782471706996113408
author Luo, Chun
Ke, Yuting
Yuan, Yanyan
Zhao, Ming
Wang, Fuyan
Zhang, Yisheng
Bu, Shizhong
author_facet Luo, Chun
Ke, Yuting
Yuan, Yanyan
Zhao, Ming
Wang, Fuyan
Zhang, Yisheng
Bu, Shizhong
author_sort Luo, Chun
collection PubMed
description BACKGROUND: Radix Puerariae and hawthorn fruit have been demonstrated to treat diabetes. They offer potential benefits for preventing depression in diabetes. OBJECTIVE: The aim of this study was to investigate whether the combination of Radix Puerariae and hawthorn fruit (CRPHF) could prevent depression in a diabetic rat model generated by feeding the rats with a high-fat diet and a low-dose streptozotocin (STZ). METHODS: The CRPHF was provided by the Shanghai Chinese Traditional Medical University. Twenty-four rats were randomly divided into four groups: normal control, normal-given-CRPHF (NC), diabetic control, and diabetic-given-CRPHF (DC) groups. The type 2 diabetic model was created by feeding the rats with a high-fat diet for 4 weeks followed by injection of 25 mg/kg STZ. CRPHF was given at 2 g/kg/d to the rats of NC and DC groups by intragastric gavage daily for 4 weeks after the type 2 diabetic model was successfully created. Body weight, random blood glucose (RBG), oral glucose tolerance test, total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) were measured during the study. Depressive-like behavior was evaluated at the end of the treatment by using the open field test (OFT), the elevated plus-maze test (EPMT), locomotor activity test (LAT), and forced swimming test (FST). Levels of extracellular signal-regulated protein kinase (ERK) and brain-derived neurotrophic factor (BDNF) in the prefrontal cortex were evaluated by using Western blot. RESULTS: 1) CRPHF reduced RBG and improved glucose tolerance in diabetic rats; 2) CRPHF reduced TC and TG but did not significantly change HDL-C or LDL-C in diabetic rats; 3) CRPHF reversed the loss in body weights observed in diabetic rats; 4) CRPHF reduced depressive-like behavior as measured by OFT, EPMT, LAT, and FST; 5) BDNF was upregulated, and ERK was activated in the prefrontal cortex of diabetic rats treated with CRPHF. CONCLUSION: CRPHF has the potential of preventing depression in patients with diabetes.
format Online
Article
Text
id pubmed-5136358
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-51363582016-12-09 A novel herbal treatment reduces depressive-like behaviors and increases brain-derived neurotrophic factor levels in the brain of type 2 diabetic rats Luo, Chun Ke, Yuting Yuan, Yanyan Zhao, Ming Wang, Fuyan Zhang, Yisheng Bu, Shizhong Neuropsychiatr Dis Treat Original Research BACKGROUND: Radix Puerariae and hawthorn fruit have been demonstrated to treat diabetes. They offer potential benefits for preventing depression in diabetes. OBJECTIVE: The aim of this study was to investigate whether the combination of Radix Puerariae and hawthorn fruit (CRPHF) could prevent depression in a diabetic rat model generated by feeding the rats with a high-fat diet and a low-dose streptozotocin (STZ). METHODS: The CRPHF was provided by the Shanghai Chinese Traditional Medical University. Twenty-four rats were randomly divided into four groups: normal control, normal-given-CRPHF (NC), diabetic control, and diabetic-given-CRPHF (DC) groups. The type 2 diabetic model was created by feeding the rats with a high-fat diet for 4 weeks followed by injection of 25 mg/kg STZ. CRPHF was given at 2 g/kg/d to the rats of NC and DC groups by intragastric gavage daily for 4 weeks after the type 2 diabetic model was successfully created. Body weight, random blood glucose (RBG), oral glucose tolerance test, total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) were measured during the study. Depressive-like behavior was evaluated at the end of the treatment by using the open field test (OFT), the elevated plus-maze test (EPMT), locomotor activity test (LAT), and forced swimming test (FST). Levels of extracellular signal-regulated protein kinase (ERK) and brain-derived neurotrophic factor (BDNF) in the prefrontal cortex were evaluated by using Western blot. RESULTS: 1) CRPHF reduced RBG and improved glucose tolerance in diabetic rats; 2) CRPHF reduced TC and TG but did not significantly change HDL-C or LDL-C in diabetic rats; 3) CRPHF reversed the loss in body weights observed in diabetic rats; 4) CRPHF reduced depressive-like behavior as measured by OFT, EPMT, LAT, and FST; 5) BDNF was upregulated, and ERK was activated in the prefrontal cortex of diabetic rats treated with CRPHF. CONCLUSION: CRPHF has the potential of preventing depression in patients with diabetes. Dove Medical Press 2016-11-29 /pmc/articles/PMC5136358/ /pubmed/27942216 http://dx.doi.org/10.2147/NDT.S117337 Text en © 2016 Luo et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Luo, Chun
Ke, Yuting
Yuan, Yanyan
Zhao, Ming
Wang, Fuyan
Zhang, Yisheng
Bu, Shizhong
A novel herbal treatment reduces depressive-like behaviors and increases brain-derived neurotrophic factor levels in the brain of type 2 diabetic rats
title A novel herbal treatment reduces depressive-like behaviors and increases brain-derived neurotrophic factor levels in the brain of type 2 diabetic rats
title_full A novel herbal treatment reduces depressive-like behaviors and increases brain-derived neurotrophic factor levels in the brain of type 2 diabetic rats
title_fullStr A novel herbal treatment reduces depressive-like behaviors and increases brain-derived neurotrophic factor levels in the brain of type 2 diabetic rats
title_full_unstemmed A novel herbal treatment reduces depressive-like behaviors and increases brain-derived neurotrophic factor levels in the brain of type 2 diabetic rats
title_short A novel herbal treatment reduces depressive-like behaviors and increases brain-derived neurotrophic factor levels in the brain of type 2 diabetic rats
title_sort novel herbal treatment reduces depressive-like behaviors and increases brain-derived neurotrophic factor levels in the brain of type 2 diabetic rats
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5136358/
https://www.ncbi.nlm.nih.gov/pubmed/27942216
http://dx.doi.org/10.2147/NDT.S117337
work_keys_str_mv AT luochun anovelherbaltreatmentreducesdepressivelikebehaviorsandincreasesbrainderivedneurotrophicfactorlevelsinthebrainoftype2diabeticrats
AT keyuting anovelherbaltreatmentreducesdepressivelikebehaviorsandincreasesbrainderivedneurotrophicfactorlevelsinthebrainoftype2diabeticrats
AT yuanyanyan anovelherbaltreatmentreducesdepressivelikebehaviorsandincreasesbrainderivedneurotrophicfactorlevelsinthebrainoftype2diabeticrats
AT zhaoming anovelherbaltreatmentreducesdepressivelikebehaviorsandincreasesbrainderivedneurotrophicfactorlevelsinthebrainoftype2diabeticrats
AT wangfuyan anovelherbaltreatmentreducesdepressivelikebehaviorsandincreasesbrainderivedneurotrophicfactorlevelsinthebrainoftype2diabeticrats
AT zhangyisheng anovelherbaltreatmentreducesdepressivelikebehaviorsandincreasesbrainderivedneurotrophicfactorlevelsinthebrainoftype2diabeticrats
AT bushizhong anovelherbaltreatmentreducesdepressivelikebehaviorsandincreasesbrainderivedneurotrophicfactorlevelsinthebrainoftype2diabeticrats
AT luochun novelherbaltreatmentreducesdepressivelikebehaviorsandincreasesbrainderivedneurotrophicfactorlevelsinthebrainoftype2diabeticrats
AT keyuting novelherbaltreatmentreducesdepressivelikebehaviorsandincreasesbrainderivedneurotrophicfactorlevelsinthebrainoftype2diabeticrats
AT yuanyanyan novelherbaltreatmentreducesdepressivelikebehaviorsandincreasesbrainderivedneurotrophicfactorlevelsinthebrainoftype2diabeticrats
AT zhaoming novelherbaltreatmentreducesdepressivelikebehaviorsandincreasesbrainderivedneurotrophicfactorlevelsinthebrainoftype2diabeticrats
AT wangfuyan novelherbaltreatmentreducesdepressivelikebehaviorsandincreasesbrainderivedneurotrophicfactorlevelsinthebrainoftype2diabeticrats
AT zhangyisheng novelherbaltreatmentreducesdepressivelikebehaviorsandincreasesbrainderivedneurotrophicfactorlevelsinthebrainoftype2diabeticrats
AT bushizhong novelherbaltreatmentreducesdepressivelikebehaviorsandincreasesbrainderivedneurotrophicfactorlevelsinthebrainoftype2diabeticrats